Patients with cardiovascular disease may be especially prone to the adverse effects of complementary medicines
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in Australia.1 Given the chronic nature of CVD, medical management is the most common mode of care, and medications are prescribed to most patients with CVD.2 In general practice, treatment of CVD accounts for almost one in five encounters, with hypertension the most commonly treated risk factor, followed by lipid disorders.2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Institute of Health and Welfare. Australia’s Health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.) http://www.aihw.gov.au/publication-detail/?id=6442468102 (accessed Oct 2011).
- 2. Australian Institute of Health and Welfare. General practice activity in Australia 2005–06. Canberra: AIHW, 2007. (AIHW Cat. No. GEP 19.) http://www.aihw.gov.au/publication-detail/?id=6442467936 (accessed Oct 2011).
- 3. Therapeutic Drugs Administration. The regulation of complementary medicines in Australia — an overview. Canberra: TGA, 2007. http://www.tga. gov.au/industry/cm-basics-regulation-overview.htm (accessed Oct 2011).
- 4. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ 2000; 78: 252-257.
- 5. Bin YS, Kiat H. Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease. Evid Based Complement Alternat Med 2011; article ID: 632829. doi: 10.1155/2011/632829.
- 6. Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010; 55: 515-525.
- 7. Cohen PA, Ernst E. Safety of herbal supplements: a guide for cardiologists. Cardiovasc Ther 2010; 28: 246-253.
- 8. Izzo AA, Di Carlo G, Borrelli F, Ernst E. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol 2005; 98: 1-14.
- 9. Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 2004; 12: 90-98.
- 10. Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med 2010; 7: 11-28.
- 11. Bishop FL, Yardley L, Lewith GT. A systematic review of beliefs involved in the use of complementary and alternative medicine. J Health Psychol 2007; 12: 851-867.
- 12. Pirotta M, Kotsirilos V, Brown J, et al. Complementary medicine in general practice — a national survey of GP attitudes and knowledge. Aust Fam Physician 2010; 39: 946-950.
- 13. Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189: 19-30.
- 14. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001; 285: 304-312.
- 15. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002; 287: 1815-1821.
- 16. Zhao YT, Chen Q, Sun YX, et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med 2009; 41: 301-310.
- 17. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol 2007; 49: 2231-2237.
- 18. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 2003; 18: 91-100.
- 19. Lee MS, Pittler MH, Guo R, Ernst E. Qigong for hypertension: a systematic review of randomized clinical trials. J Hypertens 2007; 25: 1525-1532.
We thank Lisa Wallis for assistance in manuscript preparation.
No relevant disclosures.